Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction

Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77(1):38–52. https://doi.org/10.1016/j.eururo.2019.08.005

Liu X, Yu C, Bi Y, Zhang ZJ (2019) Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health 172:70–80. https://doi.org/10.1016/j.puhe.2019.04.016

Ma CG, Ye DW, Li CL et al (2008) Epidemiology of prostate cancer from three centers and analysis of the first-fine hormonal therapy for the advanced disease[in Chinese]. Chin J Surg 46(12):921–925. https://doi.org/10.3321/j.issn:0529-5815.2008.12.012

Teo MY, Rathkopf DE, Kantoff P (2019) Treatment of advanced prostate cancer. Annu Rev Med 70:479–499. https://doi.org/10.1146/annurev-med-051517-011947

Lee F, Torp-Pedersen ST, Siders DB (1989) The role of transrectal ultrasound in the early detection of prostate cancer. CA Cancer J Clin 39(6):337–360

Hamilton W, Sharp DJ, Peters TJ, Round AP (2006) Clinical features of prostate cancer before diagnosis: a population-based, case-control study. Br J Gen Pract 56(531):756–762

Hamilton W, Sharp D (2004) Symptomatic diagnosis of prostate cancer in primary care: a structured review. Br J Gen Pract 54(505):617–621

Ok JH, Meyers FJ, Evans CP (2005) Medical and surgical palliative care of patients with urological malignancies. J Urol 174(4 Pt 1):1177–1182. https://doi.org/10.1097/01.ju.0000173077.84274.01

Xia S-J, Zhuo J, Sun X-W, Han B-M, Shao Y, Zhang Y-N (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389. https://doi.org/10.1016/j.eururo.2007.05.019

Schaeffer E, Srinivas S, Antonarakis ES et al (2021) NCCN guidelines insights: prostate cancer, version 1.2021. J Natl Compr Canc Netw 19(2):134–143. https://doi.org/10.6004/jnccn.2021.0008

Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79(2):263–282. https://doi.org/10.1016/j.eururo.2020.09.046

Lehrer S, Stone NN, Droller MJ, Stock RG (2002) Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer. Urol Oncol 7(2):73–76. https://doi.org/10.1016/s1078-1439(01)00155-7

Rom M, Waldert M, Schatzl G, Swietek N, Shariat SF, Klatte T (2014) Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer. BJU Int 114(1):62–66. https://doi.org/10.1111/bju.12438

Franiel T, Lüdemann L, Rudolph B et al (2009) Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 252(1):101–108. https://doi.org/10.1148/radiol.2521081400

Rieken M, Bachmann A (2014) Laser treatment of benign prostate enlargement–which laser for which prostate? Nat Rev Urol 11(3):142–152. https://doi.org/10.1038/nrurol.2014.23

Tanaka M, Suzuki N, Nakatsu H, Murakami S, Matsuzaki O, Shimazaki J (2003) Significance of capsular attachment and invasion of cancer tissues in prostate cancer. Int J Urol 10(6):309–314

Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243–262. https://doi.org/10.1016/j.eururo.2020.09.042

Shankar PR, Ellimoottil C, George AK et al (2021) Testing-related health impact of transrectal and transperineal prostate biopsy as assessed by health utilities. J Urol 206(6):1403–1410. https://doi.org/10.1097/JU.0000000000002118

Chang DTS, Challacombe B, Lawrentschuk N (2013) Transperineal biopsy of the prostate–is this the future? Nat Rev Urol 10(12):690–702. https://doi.org/10.1038/nrurol.2013.195

Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892. https://doi.org/10.1016/j.eururo.2013.05.049

Ploussard G, Dubosq F, Boublil V et al (2009) Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen. J Urol 182(4):1342–1349. https://doi.org/10.1016/j.juro.2009.06.050

Lin C-C, Huang WJS, Wu L-J, Chang Y-H, Lin ATL, Chen K-K (2008) Diagnosis of prostate cancer: repeated transrectal prostate biopsy or transurethral resection. J Chin Med Assoc 71(9):448–454. https://doi.org/10.1016/S1726-4901(08)70147-3

Fang K, Song P, Zhang J et al (2021) The impact of palliative transurethral resection of the prostate on the prognosis of patients with bladder outlet obstruction and metastatic prostate cancer: a population-matched study. Front Surg 8:726534. https://doi.org/10.3389/fsurg.2021.726534

Choi SY, Ryu J, You D et al (2018) Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study. J Cancer Res Clin Oncol 144(4):751–758. https://doi.org/10.1007/s00432-018-2597-5

Qu M, Zhu F, Chen H et al (2019) Palliative transurethral resection of the prostate in patients with metastatic prostate cancer: a prospective study of 188 patients. J Endourol 33(7):570–575. https://doi.org/10.1089/end.2019.0108

Heung YM, Walsh K, Sriprasad S, Mulvin D, Sherwood RA (2000) The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate. BJU Int 85(1):65–69. https://doi.org/10.1046/j.1464-410x.2000.00380.x

Moreno JG, O’Hara SM, Long JP et al (1997) Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology 49(4):515–520. https://doi.org/10.1016/s0090-4295(97)00016-2